Fundraising FoxKinimmune
1 known investors
Find your way into Kinimmune
Sign up to see every warm intro you have to Kinimmune
- Paths you didn't know you had: your email and LinkedIn already hold routes to the Kinimmune team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Kinimmune develops localized immunotherapies that activate the immune system at the site of solid tumors. Its lead program, KIN-112, pairs a proprietary peptide with a TLR agonist to concentrate treatment within the tumor and mobilize immune cells against cancer.
Investors · 1
Frequently asked questions
- What does Kinimmune do?
- Kinimmune develops localized immunotherapies that activate the immune system at the site of solid tumors. Its lead program, KIN-112, pairs a proprietary peptide with a TLR agonist to concentrate treatment within the tumor and mobilize immune cells against cancer.
- Who are Kinimmune's investors?
- Kinimmune's investors include BioGenerator Ventures.